Effectiveness of Adjuvanted Recombinant Zoster Vaccine (RZV) Against Postherpetic Neuralgia (PHN) and Against Cardiovascular Disease (CVD) Events After Herpes Zoster (HZ) in United States Adults in Medicare Fee-for-Service (FFS) + Inovalon’s MORE2 Registry (307298 - EPI-ZOSTER-116 VE DB US)

Data sources

• Data source(s):
  Other data source
• Data source(s), other:
  This study will leverage 100% Medicare FFS data and the MORE2 Registry database at Inovalon. ; Veritas Data Research mortality data.
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Other
• Data sources (types), other:
  Mortality data

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Yes
• Check completeness:
  Yes
• Check stability:
  Yes
• Check logical consistency:
  Yes

Data characterisation

• Data characterisation conducted:
  Yes